UNLABELLED: Serotonin (5-HT) dysfunction has been implicated in neuropsychiatric illnesses and may play a pivotal role in the differential prevalence of depression between the sexes. Previous PET studies have revealed sex-based differences in 5-HT1A binding potential (BPND). The binding potential is a function of the radioligand-receptor affinity (1/KDapp), and receptor density (Bmax). In this work, we use a multiple-injection (MI) PET protocol and the 5-HT1A receptor antagonist, [(18)F]mefway, to compare sex-based differences of in vivo affinity, Bmax, and BPND in rhesus monkeys. METHODS: PET [(18)F]mefway studies were performed on 17 (6m, 11f) rhesus monkeys using a 3-injection protocol that included partial saturation injections of mefway. Compartmental modeling was performed using a model to account for non-tracer doses of mefway for the estimation of KDapp and Bmax. BPND estimates were also acquired from the first injection (high specific activity [(18)F]mefway, 90-minute duration) for comparison using the cerebellum (CB) as a reference region. Regions of interest were selected in 5-HT1A binding regions of the hippocampus (Hp), dorsal anterior cingulate cortex (dACC), amygdala (Am), and raphe nuclei (RN). RESULTS: Female subjects displayed significantly (*p<0.05) lower KDapp in the Hp (-32%), Am (-38%), and RN (-37%). Only the Hp displayed significant differences in Bmax with females having a Bmax of -29% compared to males. Male subjects demonstrated significantly lower BPND measurements in the Am (14%) and RN (29%). CONCLUSION: These results suggest that the higher BPND values found in females are the result of lower [(18)F]mefway KDapp. Although a more experimentally complex measurement, separate assay of KDapp and Bmax provides a more sensitive measure than BPND to identify the underlying differences between females and males in 5-HT1A function.
UNLABELLED: Serotonin (5-HT) dysfunction has been implicated in neuropsychiatric illnesses and may play a pivotal role in the differential prevalence of depression between the sexes. Previous PET studies have revealed sex-based differences in 5-HT1A binding potential (BPND). The binding potential is a function of the radioligand-receptor affinity (1/KDapp), and receptor density (Bmax). In this work, we use a multiple-injection (MI) PET protocol and the 5-HT1A receptor antagonist, [(18)F]mefway, to compare sex-based differences of in vivo affinity, Bmax, and BPND in rhesus monkeys. METHODS: PET [(18)F]mefway studies were performed on 17 (6m, 11f) rhesus monkeys using a 3-injection protocol that included partial saturation injections of mefway. Compartmental modeling was performed using a model to account for non-tracer doses of mefway for the estimation of KDapp and Bmax. BPND estimates were also acquired from the first injection (high specific activity [(18)F]mefway, 90-minute duration) for comparison using the cerebellum (CB) as a reference region. Regions of interest were selected in 5-HT1A binding regions of the hippocampus (Hp), dorsal anterior cingulate cortex (dACC), amygdala (Am), and raphe nuclei (RN). RESULTS: Female subjects displayed significantly (*p<0.05) lower KDapp in the Hp (-32%), Am (-38%), and RN (-37%). Only the Hp displayed significant differences in Bmax with females having a Bmax of -29% compared to males. Male subjects demonstrated significantly lower BPND measurements in the Am (14%) and RN (29%). CONCLUSION: These results suggest that the higher BPND values found in females are the result of lower [(18)F]mefway KDapp. Although a more experimentally complex measurement, separate assay of KDapp and Bmax provides a more sensitive measure than BPND to identify the underlying differences between females and males in 5-HT1A function.
Authors: C Tai; A Chatziioannou; S Siegel; J Young; D Newport; R N Goble; R E Nutt; S R Cherry Journal: Phys Med Biol Date: 2001-07 Impact factor: 3.609
Authors: Dustin W Wooten; Ansel T Hillmer; Jeffrey M Moirano; Elizabeth O Ahlers; Maxim Slesarev; Todd E Barnhart; Jogeshwar Mukherjee; Mary L Schneider; Bradley T Christian Journal: J Cereb Blood Flow Metab Date: 2012-04-04 Impact factor: 6.200
Authors: Ramin V Parsey; Maria A Oquendo; Norman R Simpson; R Todd Ogden; Ronald Van Heertum; Victoria Arango; J John Mann Journal: Brain Res Date: 2002-11-08 Impact factor: 3.252
Authors: D W Wooten; J D Moraino; A T Hillmer; J W Engle; O J Dejesus; D Murali; T E Barnhart; R J Nickles; R J Davidson; M L Schneider; J Mukherjee; B T Christian Journal: Synapse Date: 2010-12-08 Impact factor: 2.562
Authors: C Cidis Meltzer; W C Drevets; J C Price; C A Mathis; B Lopresti; P J Greer; V L Villemagne; D Holt; N S Mason; P R Houck; C F Reynolds; S T DeKosky Journal: Brain Res Date: 2001-03-23 Impact factor: 3.252
Authors: Bradley T Christian; Dustin W Wooten; Ansel T Hillmer; Dana L Tudorascu; Alexander K Converse; Colleen F Moore; Elizabeth O Ahlers; Todd E Barnhart; Ned H Kalin; Christina S Barr; Mary L Schneider Journal: J Neurosci Date: 2013-02-06 Impact factor: 6.167
Authors: Ansel T Hillmer; Dustin W Wooten; Alisha K Bajwa; Andrew T Higgins; Patrick J Lao; Tobey J Betthauser; Todd E Barnhart; Howard A Rowley; Charles K Stone; Sterling C Johnson; Jogeshwar Mukherjee; Bradley T Christian Journal: J Nucl Med Date: 2014-11-13 Impact factor: 10.057
Authors: Jogeshwar Mukherjee; Alisha K Bajwa; Dustin W Wooten; Ansel T Hillmer; Min-Liang Pan; Suresh K Pandey; Neil Saigal; Bradley T Christian Journal: J Comp Neurol Date: 2015-11-18 Impact factor: 3.215
Authors: Ansel T Hillmer; Dustin W Wooten; Dana L Tudorascu; Todd E Barnhart; Elizabeth O Ahlers; Leslie M Resch; Julie A Larson; Alexander K Converse; Colleen F Moore; Mary L Schneider; Bradley T Christian Journal: Drug Alcohol Depend Date: 2014-08-29 Impact factor: 4.492
Authors: Ansel T Hillmer; Dustin W Wooten; Maxim S Slesarev; Elizabeth O Ahlers; Todd E Barnhart; Mary L Schneider; Jogeshwar Mukherjee; Bradley T Christian Journal: J Cereb Blood Flow Metab Date: 2013-08-14 Impact factor: 6.200